Digital leaders and key stakeholders from across the pharmaceutical value chain will convene at the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024) to discuss emerging trends and the latest solutions for digital transformation in the industry. Continuing its tradition, the Congress will take place in Zurich, Switzerland, on November 18-19, 2024, at the heart of the pharmaceutical sector.
Each year, the Pharmaceutical Automation and Digitalisation Congress brings together prominent figures from the pharma industry for valuable networking and knowledge-sharing opportunities.
“As this event is tailored for networking, I find ample time to engage in meaningful discussions. The closed nature of the event allows for deeper conversations,” shared Alex Raychuk, Founder & CEO of Medentee Limited, during an interview at the 2023 Congress.
In 2024, AUTOMA+ invites pharmaceutical companies, CMOs, CDMOs, CROs, API manufacturers, and industry associations to explore innovative strategies that enhance operational efficiency within the sector.
The two-day agenda features a variety of participation formats, including panel discussions, sessions, keynote talks, and roundtables, focusing on two primary themes:
- Digital transformation across pharmaceutical processes (R&D, manufacturing, packaging and labeling, supply chain).
- Key industry trends (patient-centricity, sustainability, AI, ChatGPT, data ecosystems, regulatory challenges, privacy, and collaborations).
The Congress offers participants the chance to discover cutting-edge digital solutions and forge long-term partnerships. Confirmed delegates include representatives from renowned companies such as Novo Nordisk, Takeda, Novartis, TEVA, Lundbeck, Merck, Medical Information Leaders Europe, and Cipla, among others.
